Clinical Trials Browser

Neoplasms × anlotinib × Thoracic × Clear all

NCT03736837 2021-03-15

ALTER-L004

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02388919 2017-09-18

ALTER0303

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01924195 2015-10-28

Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms